solid lipid nanoparticles

The solubility and bioavailability of a drug is very important while preparing a formulation. BCS class-II drugs like clopidogrel have the problem of poor bioavailability because of less solubility.so many novel techniques were available to improve the solubility aspects of drug among which solid lipid nanoparticles is a promising approach.in the current study attempts were made to formulate and evaluate clopidogrel loaded solid lipid nanoparticles by employing cutina as lipid and lecithin soya and PEG-400 and TWEEN-80 were used as surfactant systems. Different formulations were prepared and analyzed for drug content, entrapment efficiency, drug release studies. The selected formulations were analyzed with stability studies at two different conditions which is, room temperature and refrigerated conditions.

Curcumin a hydrophobic poly-phenol is derived from turmeric, the rhizome of the herb Curcuma longa L. Curcumin has been shown to exert anti-depressant effects in rodent models. However, poor bioavailability of curcumin curbs its usage as a therapeutic agent. In view of the above curcumin loaded solid lipid nanoparticles (C-SLNs) were prepared and evaluated for the antidepressant effect of acute administration of C-SLNs (1, 2.5, 5 and 10 mg/kg, p.o.) in the forced swim model of depression in mice. C-SLNs exhibited 47.42%, 67.39%, 31.67% and 36.2% reduction in immobility time after administration of 1, 2.5, 5 or 10 mg/kg dose (p.o.) respectively. Free curcumin however did not result in a significant reduction, except at 2.5 mg/kg, which could produce a reduction of 21.7% but was still 2.83 times lower than the effect obtained with a similar dose of C-SLNs. The results obtained may be assigned to the therapeutic amounts of curcumin reaching the brain. Thus, C-SLNs with their improved bioavailability and permeability possess higher anti-depressant potential upon administration of a single and a much lower dose when compared to free curcumin.